Skip to main content

Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.

An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.

Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.

This chapter was published in IP in the Life Sciences.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
May 06, 2026

First published by Lexology. Authors: Safir Anand and Rashi Chandhoke In recent years, the intellectual property (IP) ecosystem has undergone a significant

India Waives IP Filing Fees for Sports Sector
News & Updates, Thought Leadership
Apr 30, 2026

‘First published on India Business Law Journal’ By: Pravin Anand and Prachi Agarwal The concept of a family of marks in the context of the Trademark

‘Family of marks’ doctrine in India
News & Updates, Thought Leadership
Mar 18, 2026

First published by Lexology. Authors: Safir Anand and Sehr Anand Intellectual property Design protection Which IP rights are applicable to fashion designs?

Snapshot: intellectual property for fashion goods in India
News & Updates, Thought Leadership
Mar 16, 2026

‘First published on Asia IP’ By: Ritika Ahuja Patents in India are governed by the Patents Act, 1970. A patent is a statutory right granted to the

When does public display become prior art: Anticipation under the Patents Act, 1970